KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Equity Average (2017 - 2026)

Elanco Animal Health's Equity Average history spans 9 years, with the latest figure at $6.6 billion for Q4 2025.

  • On a quarterly basis, Equity Average rose 5.36% to $6.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.6 billion, a 5.36% increase, with the full-year FY2025 number at $6.3 billion, up 2.63% from a year prior.
  • Equity Average hit $6.6 billion in Q4 2025 for Elanco Animal Health, down from $6.8 billion in the prior quarter.
  • Over the last five years, Equity Average for ELAN hit a ceiling of $8.2 billion in Q1 2021 and a floor of $6.0 billion in Q2 2024.
  • Historically, Equity Average has averaged $7.0 billion across 5 years, with a median of $6.8 billion in 2022.
  • Biggest five-year swings in Equity Average: surged 34.91% in 2021 and later fell 19.48% in 2024.
  • Tracing ELAN's Equity Average over 5 years: stood at $7.6 billion in 2021, then decreased by 7.81% to $7.0 billion in 2022, then decreased by 11.75% to $6.2 billion in 2023, then increased by 2.12% to $6.3 billion in 2024, then grew by 5.36% to $6.6 billion in 2025.
  • Business Quant data shows Equity Average for ELAN at $6.6 billion in Q4 2025, $6.8 billion in Q3 2025, and $6.6 billion in Q2 2025.